<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="article-commentary" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neurogenesis (Austin)</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurogenesis (Austin)</journal-id>
<journal-id journal-id-type="publisher-id">KNGS</journal-id>
<journal-id journal-id-type="publisher-id">kngs20</journal-id>
<journal-title-group>
<journal-title>Neurogenesis</journal-title>
</journal-title-group>
<issn pub-type="epub">2326-2133</issn>
<publisher>
<publisher-name>Taylor &amp; Francis</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28203608</article-id>
<article-id pub-id-type="pmc">5293320</article-id>
<article-id pub-id-type="publisher-id">1270384</article-id>
<article-id pub-id-type="doi">10.1080/23262133.2016.1270384</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Commentary</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Modeling Fragile X syndrome in neurogenesis: An unexpected phenotype and a novel tool for future therapies</article-title>
<alt-title alt-title-type="running-authors">B. BARDONI ET AL.</alt-title>
<alt-title alt-title-type="running-title">NEUROGENESIS</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bardoni</surname>
<given-names>Barbara</given-names>
</name>
<xref ref-type="aff" rid="af0001">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="af0002">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="af0003">
<sup>c</sup>
</xref>
<xref ref-type="corresp" rid="an0001"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Capovilla</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="af0001">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="af0004">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lalli</surname>
<given-names>Enzo</given-names>
</name>
<xref ref-type="aff" rid="af0001">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="af0002">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="af0003">
<sup>c</sup>
</xref>
</contrib>
<aff id="af0001"><label>a</label><institution>Université Côte d'Azur</institution>, Nice, <country>France</country></aff>
<aff id="af0002"><label>b</label><institution>CNRS UMR7275, Institut of Molecular and Cellular Pharmacology</institution>, Valbonne, <country>France</country></aff>
<aff id="af0003"><label>c</label><institution>CNRS LIA « NEOGENEX »</institution>, Valbonne, <country>France</country></aff>
<aff id="af0004"><label>d</label><institution>UMR 1355–7254 INRA/CNRS, Institut Sophia Agrobiotech</institution>, Sophia Antipolis, <country>France</country></aff>
</contrib-group>
<author-notes>
<corresp id="an0001"><bold>CONTACT</bold> Barbara Bardoni <email xlink:href="bardoni@ipmc.cnrs.fr">bardoni@ipmc.cnrs.fr</email><institution>CNRS UMR7275</institution>, <addr-line>660 Route des Lucioles</addr-line>, 06560 Valbonne, <country>France</country></corresp>
</author-notes>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>31</day>
<month>1</month>
<year>2017</year>
</pub-date>
<volume>4</volume>
<issue>1</issue>
<elocation-id seq="1">e1270384</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>10</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>30</day>
<month>11</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>2</day>
<month>12</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017 Taylor &amp; Francis</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Taylor &amp; Francis</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="kngs-04-01-1270384.pdf"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p>FMRP is an RNA-binding protein involved in synaptic translation. Its absence causes a form of intellectual disability, the Fragile X syndrome (FXS). Small neuroanatomical abnormalities, present both in human and mouse FMRP-deficient brains, suggest a subtle critical role of this protein in neurogenesis. Stable depletion of FMRP has been obtained in a mouse embryonic stem cell line <italic>Fmr1</italic> (<italic>shFmr1</italic> ES) that does not display morphological alterations, but an abnormal expression of a subset of genes mainly involved in neuronal differentiation and maturation. Inducing the differentiation of sh<italic>Fmr1</italic> ES cells into the neuronal lineage results in an accelerated generation of neural progenitors and neurons during the first steps of neurogenesis. This transient phenotype is due to an elevated level of the Amyloid Precursor Protein (APP), whose mRNA is a target of FMRP. APP is processed by the BACE-1 enzyme, producing the β-amyloid (Aβ) peptide accelerating neurogenesis by activating the expression of <italic>Ascll.</italic> Inhibition of the BACE-1 enzyme rescues the phenotype of sh<italic>Fmr1</italic> ES cells.</p>
<p>Here we discuss the importance of the sh<italic>Fmr1</italic> ES line not only to understand the physiopathology of FXS but also as a tool to screen biomolecules for new FXS therapies.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>KEYWORDS</title>
<kwd>cell model for Fragile X syndrome</kwd>
<kwd>Fragile X Syndrome</kwd>
<kwd>neurogenesis</kwd>
<kwd>therapy for Fragile X syndrome</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="35"></ref-count>
<page-count count="5"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>